Across TCGA pan-cancer cohorts, PHF24 mass-spec protein is linked to patient survival in 2 of 34 cancer types, making it a survival-associated PHF24 data layer compared with 20 for mass-spec protein and 7 for mutation status.
The strongest signal is observed in lung squamous cell carcinoma (LSCC), where higher PHF24 mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated PHF24 expression acts as an unfavorable survival marker, although some lineages such as GBM show a favorable association.
LSCC and GBM are the cancer types where PHF24 mass-spec protein most reproducibly stratifies survival.